UNCTIONAL assessment of the spinal cord is essential when a patient is amenable to neurosurgical treatment for cervical compressive myelopathy. Obviously, the neurological outcome after surgery is influenced largely by the resolution of spinal cord dysfunction. A number of diagnostic approaches have been used to assess preoperative spinal cord function and establish a neurological prognosis. 27, 31, 38 Most conventional approaches, however, have focused on evaluating neural conductivity across the damaged spinal cord or morphological changes at the level of the compression that can be identified on MR imaging. On the other hand, metabolic neuroimaging by PET has been used to evaluate tissue biological activity, although it has been limited mostly to supraspinal neurological disorders and other miscellaneous diseases. 13, 17, 22, 28, 37 Kamoto and colleagues 21 were the first to achieve successful visualization of the cervical spinal cord by using FDG and high-resolution PET in healthy volunteers. In a small number of cases with cervical compressive myelopathy, our group has reported a low preoperative glucose utilization rate in the cervical spinal cord and a trend toward normalization of the rate after surgery.
and 10 women), who were approached at random to volunteer for the study prior to undergoing decompressive surgery for osteocartilaginous impingement of the cervical spinal cord at one or two vertebral levels. The mean age at surgery was 54 years (range 32-71 years). Cervical spondylosis was present in 11 patients, cervical disc herniation in nine, and OPLL in three; the compressive lesion was located in the mid-cervical area between C-3 and C-7. Sixteen patients required anterior decompression and interbody fusion whereas seven underwent posterior en bloc laminoplasty in which established surgical techniques were used. 1, 3, 5 Patients presented with a wide spectrum of clinical myelopathic features. The mean duration of symptoms was 8.7 months (range 3-36 months). Patients with diabetes mellitus were excluded from the study. The mean follow-up period was 2.2 years (range 1.8-2.6 years). Neurological status was assessed using the JOA scoring system (Table 1) ; 11, 18 clinical condition was scored preoperatively and at follow-up examination, and the rate of neurological improvement was calculated as follows:
Rate (%) = (postoperative score Ϫ preoperative score)/ (17 Ϫ preoperative score) ϫ 100.
Both PET and MR imaging studies were performed according to the Ethical Committee Guidelines of our university, and written informed consent was obtained from each patient.
Magnetic Resonance Imaging
Neuroimaging workup included routine MR imaging to evaluate the extent and degree of cervical spinal cord damage caused by the compressive lesion(s). On T 2 -weighted MR images, changes in signal intensity 27, 31 within the cervical cord around the level(s) of compression were carefully viewed using a high-resolution 1.5-tesla imager (Signa; General Electric Medical Systems, Milwaukee, WI).
Tracer Technique and PET
The tracer technique for PET scanning was followed using the GE Advance system (General Electric Medical Systems). The physical characteristics of this scanner have been described previously by DeGrado, et al., 8 and our group. 6, 21 The system allows the simultaneous acquisition of 35 transverse slices with 4.25-mm interslice spacing with septa (two-dimensional mode). Images were reconstructed to a full width at half maximum of 4.2 mm in both transaxial and axial directions. The field of view and pixel size of reconstructed images were 256 and 2 mm, respectively. Individuals were studied during a period of fasting for at least 4 hours. Transmission scans were obtained during a 10-minute interval by a standard pin source of 68 Ge/
68
Ga for attenuation correction of the emission images. A dose of 244-488 MBq of FDG was injected into the antecubital vein for 10 seconds. Dynamic scans were obtained up to 60 minutes postinjection with arterial sampling. Arterial blood was sampled from the distal artery contralateral to the injection site, after which 2-ml blood samples were obtained every 15 seconds in the first 2 minutes, and then at 2.5, 3, 5, 10, 15, 20, 30, 45 , and 60 minutes postinjection. Plasma radioactivity was measured using the scintillation counter against which the PET camera was cross-calibrated, using a cylindrical phantom filled with FDG solution. The image was processed using Doctor View software (Asahikasei, Nobeoka, Japan) on a SPARC 20 workstation (Sun Microsystems, Mountain View, CA).
For quantitative analysis, the circulatory metabolic rate of glucose was calculated on pixel-by-pixel basis using the Sokoloff three-compartment model 28, 33 and an autoradiographic method with the following equation as well as a priori estimates of the rate constants and lumped constant of normal cerebral gray matter: 16 where CMrGlc is the circulatory metabolic rate of glucose, Cp is the serum glucose level (mg/dl), LC is the lumped constant, which indicates the ratio of FDG uptake to glucose uptake, Ci(T) is radioactivity of FDG in the brain at time T, and ⊗Cp(t) denotes the convolution of plasma activity of FDG. The k values were fixed as follows (k1 in ml/min/g; k2, k3, and k4 in min The normal range of the circulatory metabolic rate of glucose of the cervical cord has not been measured precisely. After injection of FDG, Kamoto, et al., 21 measured glucose metabolism of the normal spinal cord by using a camera similar to that used in the present study. They reported that the normal glucose metabolic rate of the cervical spinal cord was 1.93 Ϯ 0.37 mg/100 g/min g of brain (mean age 65.5 Ϯ 8.5 years), which was consistent with the rate reported earlier by Di Chiro, et al., 10 of 1.7 Ϯ 0.6 mg/100 g/min of brain, taking into consideration the difference of the spatial resolution of the different PET cameras. The SUV is the tissue activity normalized with the injected dose per body weight (mg/ml). 21 The SUV is linearly related to the metabolic rate of glucose with the assumption of a negligible k4 value:
where MrGlc is the metabolic rate of glucose, Ki is the net influx constant k1•k3/(k2 ϩ k3), Kp is the mean plasma clearance rate of FDG up to the imaging time (uptake period), and Vo is the initial distribution volume of FDG. The Kp and Vo are known to be relatively constant across individuals. 29 Hence, SUV reflects the MrGlc, and with euglycemic conditions and constant uptake period, quantitative comparison across individuals is possible. In the present study, we tentatively used the SUV to report the level of glucose utilization in the cervical cord, similar to the studies of Mazziotta and colleagues, 25, 26 Kim, et al., 24 and Shields, et al. High-resolution FDG-PET for cervical myelopathy
To determine the aforementioned parameters of cervical cord glucose metabolism, round ROIs, each 10.3 mm in diameter (21 pixels), were placed on the spinal cord in every transaxial slice ( Fig. 1) , and sagittal images were used as an "on-line" reference to place ROI. During placement of ROI, a sagittal MR image served as reference to match the level of the ROI placed with the entire cervical spinal cord. The maximal count in the ROI was then adopted as the tissue radioactivity to eliminate the partial volume effect caused by the slightly larger size of the ROI than the diameter of the spinal cord. 12, 15, 19, 23 The ROI values at all levels of the cervical cord were averaged to calculate the mean SUV. These values represented the metabolic activity of the cervical spinal cord as a whole.
Statistical Analysis
We then examined the correlation between ages, duration of symptoms, JOA scores, and mean SUV by using the Spearman correlation test running the SPSS11.0J program (SPSS, Inc., Chicago, IL) with the level of significance set at a probability value less than 0.05. The relationships between high signal intensity on T 2 -weighted MR images and other clinical data were examined using the Mann-Whitney U-test. Table 2 provides a summary of data obtained in all 23 patients included in the study. Symptoms and signs of myelopathy exhibited in all patients with a mean JOA score of 13.5 Ϯ 2.3 preoperatively (range 8-16). Neurological improvement was observed postoperatively in all patients, and the mean follow-up score increased to 15.5 Ϯ 1.8 (range [10] [11] [12] [13] [14] [15] [16] [17] . Thus, the rate of postoperative neurological improvement was 67.6 Ϯ 25.6% (range 22.2-100%). The mean metabolic rate of glucose of the compressed cervical cord was 2.16 Ϯ 0.4 mg/100 g/min (range 1.56-3.04 mg/100 g/min). The mean SUV of the compressed cervical cord was 2.14 Ϯ 0.41 mg/ml (range 1.52-3.08 mg/ml). On preoperative T 2 -weighted MR images, focal high intensity areas within the cord at and around the level of compressive lesions were demonstrated in 12 patients.
Results

Summary of Clinical and Neuroimaging Data
Correlation Between Mean SUV and Other Parameters
Figure 2 provides a preoperative T 2 -weighted midsagittal MR image, a midsagittal PET image, and the SUV values at various cervical vertebral levels in a representative patient (Case 15). The preoperative SUV value averaged across the entire cervical spinal cord in this patient was higher than the mean value calculated for all patients. In Case 15, pre-and postoperative neurological scores were 14 and 17, respectively, and the surgery-related outcome was excellent (rate of neurological improvement 100%). Figure 3 provides a preoperative T 2 -weighted midsagittal MR image, a midsagittal PET image, and the SUV values at various cervical vertebral levels obtained in another patient (Case 7). The preoperative SUV value averaged across the entire cervical spinal cord was low relative to the mean value calculated in all patients. In Case 7, preand postoperative neurological scores were 10 and 12, respectively, and the surgery-related outcome was fair (rate of neurological improvement 28.5%).
The estimated SUV at the affected vertebral level did not show a consistent pattern relative to that of unaffected segments in most patients. There was no significant correlation between the mean SUV in patients with myelopathy and age (r = Ϫ0.107, p = 0.626), nor duration of symptoms (r = 0.036, p = 0.869). The mean SUV in patients with myelopathy correlated significantly with JOA scores (r = 0.497, p = 0.016) measured preoperatively (Fig. 4A) . Although there was a trend for an increased JOA score postoperatively with high SUV, the correlation was significant (r = 0.595, p = 0.003, Fig. 4B ). The mean SUV correlated significantly with the rate of neurological improvement postoperatively (r = 0.538, p = 0.008 [ Fig. 4C]) .
Correlation of High-Intensity Areas on MR Imaging and Other Parameters
The presence of a high-intensity area on T 2 -weighted MR imaging did not correlate with age at surgery, duration of symptoms, preoperative JOA score, postoperative JOA score, and the mean SUV (Table 3) .
Discussion
The capacity of the damaged spinal cord to recover functionally is a subject of great interest. Many attempts have been made neuroradiologically to understand the reversibility of neurological dysfunction of the spinal cord. 3, 5, 12, 38 Because profound paresis reflects serious spinal cord damage, we have been interested in correlating this neurological symptom, as well as surgery-related outcome, with MR imaging abnormalities. 3, 5 In this regard, Weirich, et al., 36 correlated changes in MR signal with the histopathological changes in a model of acute spinal cord compression. These signal intensity changes, however, do not always reflect cord function or neurological prognosis, 27, 31 particularly in chronic cases with progressive OPLL. At present, we believe that MR imaging is the most valuable tool for assessing the extent and degree of the compressive lesion impinging on the spinal cord, although not for investigating spinal cord function itself. In this regard, we agree with Budinger and Taylor 7 that PET imaging may be useful for examining the functional activity of the damaged tissue, including the spinal cord.
To our knowledge, Di Chiro, et al., 9, 10 were the first group to demonstrate and quantitate the FDG utilization rate of the cervical cord in 34 healthy volunteers and patients by using a high-resolution PET scanner (Neuro-PET; National Institutes of Health, Bethesda, MD), with a maximum resolution of 6 mm. In their reports, the mean glucose utilization of apparently normal upper cervical cord was 1.7 Ϯ 0.6 mg/100 g/min. They also described asymmetrical utilization of glucose in patients with highor low-grade neoplasm of the spinal cord. More recently, Higano and coworkers 14 used [ 11 C]methionine-PET scanning to identify the pathological viability of a cervical intramedullary ependymoma, and they stressed the potential usefulness of PET for assessing spinal cord function.
Although our FDG-PET results may be of a preliminary nature, we derived important information regarding circulatory glucose utilization. In patients with profound myelopathy low glucose utilization rates tended to be present compared with healthy individuals. 21 These findings might reflect reduced metabolic activity of the cervical cord or motor neurons. Furthermore, the preoperative glucose utilization rate also tended to correlate with the postoperative neurological score. The mean SUV in patients with myelopathy also correlated significantly with the rate of neurological improvement postoperatively. Analysis of these findings indicates that PET scanning may be useful for evaluating neurological prognosis-that is, the preoperative glucose utilization rate can probably be used to predict the neurological outcome after surgery.
Admittedly, our results showed some degree of overlap in the mean SUV despite the presence of similar neurological features of myelopathy. The exact mechanism of such variability in glucose utilization rate is unclear. During the early stages of the disease, spinal cord compression may result in increased neuropeptide metabolic activity in neurons and glial cells in response to external pressure stimulation, possibly increasing glucose utilization. This notion is based on recent studies performed in our laboratory. 2, 4 Using a specific murine (twy/twy) model of spinal cord mechanical compression, our group also found a significant increase in the total area of somatic bodies as well as the number and length of dendrites of cervical cord motor neurons in response to compression. to the maximal compression site. 35 Such neuronal response may also occur in human cervical cord in the presence of a variable level of compression, which may explain the increased SUV. It has also been postulated that a diminished number of anterior and/or posterior gray horn cells, in response to necrosis-and, possibly, neural apoptosis-induced injurious stimuli, 32 may also influence glucose use. We have recently described a significant decrease in the number of anterior gray horn cells that correlated linearly with a reduction in the transverse remnant area of the specific mouse cervical cord. 2, 4, 34 In support of this finding, a similar neuronal loss has also been confirmed by Kameyama and colleagues 19, 20 in a human cadaver. We speculate that such neuronal loss may result in reduced FDG use. Thus, differences in the pathological condition, time course, and the extent of spinal cord damage may, individually or together, influence the glucose utilization rate.
Other issues related to the clinical use of FDG-PET imaging should be also carefully considered, including elucidation of the minimum threshold of FDG utilization rate to define postoperative neurological improvement, consideration of the surgical indications of FDG-PET imaging, and, most importantly, detailed correlation between FDG use and spinal cord neural function. If we are able to determine the threshold level of FDG utilization indicative of a "critical point" of neurological reversibility, particularly at or around the level of compression, then PET imaging will be very beneficial in the management of cases involving impaired neurological function. We are confident that with further technical improvement of the method and image analysis software such correlation will be improved. Nevertheless, based on the present results, we can confidently conclude that preoperative FDG-PET imaging can detect impaired cervical glucose utilization in compressive myelopathy.
Certain technical aspects must be considered for FDG-PET to be applied clinically for assessment of the cervical cord. Unlike the cerebrum and cerebellum, the transverse area of the cervical cord is small, and thus the effect of object size on quantification during PET imaging must be carefully considered. 9, 10, 15 As Di Chiro, et al., 9, 10 have acknowledged, the hindrance to accurate measurement of glucose use in this comparatively small structure is the poor resolution of the PET scans. Thus, the use of a highresolution scanner, similar to that in our study, is essential to compensate for the reduced volume. In the present study, data acquisition was performed using two-dimensional image analysis software, resulting in a reduced sensitivity. Perhaps refinement of the analysis software will improve the measurement of glucose utilization values. Furthermore, placement of ROIs on multiple transverse slices of PET images is another significant concern. Referring to the morphometric data in normal cadavers described by Kameyama, et al., 19 the transverse area of the cervical spinal cord in Japanese individuals ranged from 51.2 Ϯ 5.3 mm 2 at C-8 to 58.5 Ϯ 7.2 mm 2 at C-6, whereas that of the gray matter ranged from 7.2 Ϯ 1.2 mm 2 at C-3 to 10.7 Ϯ 1.3 mm 2 at C-7. In a clinical study, we recently demonstrated that the transverse area of the cervical spinal cord in patients with compressive myelopathy is reduced by approximately two thirds relative to that measured in uncompressed control conditions. 4 On the other hand, Fukushima, et al., 12 demonstrated a significant re- . Bearing these morphometric descriptions in mind, one should be extremely careful when placing an ROI during FDG-PET scanning, particularly in conditions associated with a considerable reduction in transaxial area of the spinal cord or any other similar deformation.
We conclude that using FDG-PET imaging can provide qualitative and quantitative measures of diminished metabolic activity of the compromised cervical cord in patients with compressive myelopathy, and that these values correlate with the score of neurological deficit. Although many aspects of this technique remain to be resolved to optimize the procedure, this PET scanning technique is expected to be of value in assessing the metabolic activity of the compressed cervical cord.
Conclusions
We conclude that FDG-PET scanning provides qualitative and quantitative measurement of reduced metabolic activity of the compromised cervical spinal cord in patients with compressive myelopathy. Examination of the current results indicates that PET imaging is potentially useful for the assessment of metabolic activity of the compromised cervical spinal cord, which is impossible when using other conventional neurodiagnostic modalities.
